title: Patients with good collateralization may profit from cilostazol.
authors.forename: Pascal
authors.initials: P
authors.lastname: Meier
authors.forename: Andreas
authors.initials: A
authors.lastname: Indermuehle
authors.forename: Adam
authors.initials: A
authors.lastname: Timmis
mesh_terms: D023903:Coronary Restenosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015607:Stents; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles